| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief People Officer
1 company
Llewelyn Linda serves as a Chief People Officer at HCAT. Across recent SEC filings that breaks down to 0 buys and 83 sells. Those positions are worth an estimated $567K at current prices.
Historically, Llewelyn Linda's trades have earned a strong insider score of 82/100 across 44 rated trades. Over a 12-month horizon, 95.5% of those trades were profitable, with an average 12-month return of +44.4%.
The biggest single holding is HCAT (~$567K) as Chief People Officer. The recent filings there lean toward selling, a net 138,266 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 2,242 | $35.46 | $79,503.50 | -4.1% | |
| Jul 1, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 2,242 | $29.42 | $65,967.54 | -4.1% | |
| Jun 8, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 1,121 | $30.00 | $33,630.00 | -4.2% | |
| Jun 1, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 1,121 | $26.97 | $30,233.37 | -4.2% | |
| May 12, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 2,242 | $30.00 | $67,260.00 | -4.2% | |
| May 1, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 1,121 | $25.43 | $28,510.20 | -2.1% | |
| Apr 1, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 1,121 | $26.54 | $29,756.62 | -1.4% | |
| Mar 3, 2020 | HCAT Health Catalyst, Inc. | Chief People Officer | Sale+OE | 17,944 | $28.53 | $511,992.61 | -24.7% |